Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Pestalozzi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Virchows Archiv : an International Journal of Pathology|January 15, 2005
Stability of the HER2 gene after primary chemotherapy in advanced breast cancerZsuzsanna Varga, Rosmarie Caduff, Bernhard Pestalozzi
European Journal of Dermatology : EJD|February 11, 2005
Successful imiquimod treatment of multiple basal cell carcinomas after radiation therapy for Hodgkin's diseaseMirjam Beyeler, Mirjana Urosevic, Bernhard Pestalozzi, et al.
Swiss Medical Weekly|January 20, 2017
Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospitalLilian Bringolf, Bernhard Pestalozzi, Daniel Fink, et al.
Oncoimmunology|July 30, 2016
Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastasesBettina Sobottka, Bernhard Pestalozzi, Daniel Fink, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 25, 2016
Radiation recall dermatitis induced by sorafenib : A case study and review of the literatureSonja Stieb, Oliver Riesterer, Cornelia Brüssow, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the Swiss health care systemKlazien Matter-Walstra, Markus Joerger, Ursula Kühnel, et al.
Oncology Letters|July 23, 2016
Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch<sup>®</sup> system: An observational feasibility studyTobias Piegeler, Thomas Winder, Sabine Kern, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2018
Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological featuresMarkus Rechsteiner, Konstantin Dedes, Daniel Fink, et al.
Scientific Reports|January 8, 2022
Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapyCristina Zarotti, Bärbel Papassotiropoulos, Constanze Elfgen, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A descriptive analysis of the characteristics, treatment response and prognosis of hepatic dominant solid tumors undergoing selective internal radiation therapy (SIRT)Benedict Gosztonyi, Bernhard Pestalozzi, David Kenkel, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Virchows Archiv : an International Journal of Pathology|January 15, 2005
Stability of the HER2 gene after primary chemotherapy in advanced breast cancerZsuzsanna Varga, Rosmarie Caduff, Bernhard Pestalozzi
European Journal of Dermatology : EJD|February 11, 2005
Successful imiquimod treatment of multiple basal cell carcinomas after radiation therapy for Hodgkin's diseaseMirjam Beyeler, Mirjana Urosevic, Bernhard Pestalozzi, et al.
Swiss Medical Weekly|January 20, 2017
Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospitalLilian Bringolf, Bernhard Pestalozzi, Daniel Fink, et al.
Oncoimmunology|July 30, 2016
Similar lymphocytic infiltration pattern in primary breast cancer and their corresponding distant metastasesBettina Sobottka, Bernhard Pestalozzi, Daniel Fink, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 25, 2016
Radiation recall dermatitis induced by sorafenib : A case study and review of the literatureSonja Stieb, Oliver Riesterer, Cornelia Brüssow, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the Swiss health care systemKlazien Matter-Walstra, Markus Joerger, Ursula Kühnel, et al.
Oncology Letters|July 23, 2016
Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch<sup>®</sup> system: An observational feasibility studyTobias Piegeler, Thomas Winder, Sabine Kern, et al.
Journal of Cancer Research and Clinical Oncology|February 18, 2018
Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological featuresMarkus Rechsteiner, Konstantin Dedes, Daniel Fink, et al.
Scientific Reports|January 8, 2022
Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapyCristina Zarotti, Bärbel Papassotiropoulos, Constanze Elfgen, et al.
Journal of Gastrointestinal Oncology|January 13, 2023
A descriptive analysis of the characteristics, treatment response and prognosis of hepatic dominant solid tumors undergoing selective internal radiation therapy (SIRT)Benedict Gosztonyi, Bernhard Pestalozzi, David Kenkel, et al.
Pageof 3